ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.651,47
-0,16%
S&P 500
5.316,28
0,17%
Dow Jones
39.468,10
-0,51%
Euro vs US Dollar
1,08331
0,07%
Bitcoin
67.907,43
-1,73%
Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. USOTC
  6. RegeneRX Biopharmaceuticals Inc (CE) (RGRX)

  7. RegeneRX Biopharmaceuticals Inc (CE) (RGRX) News

RGRX

RegeneRX Biopharmaceutic... (CE) (RGRX)

RegeneRX Biopharmaceuticals Inc (CE)
Von:
Sortieren nach:
 Showing the most relevant articles for your search:USOTC:RGRX
DatumZeitQuelleÜberschriftSymbolFirma
14/08/202322h01Edgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
07/08/202321h57Edgar (US Regulatory)Form 8-K - Current reportUSOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
11/07/202323h13Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsUSOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
10/07/202323h19Edgar (US Regulatory)Form 8-K - Current reportUSOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
06/07/202322h35Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
06/07/202322h30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
26/06/202312h01Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
21/06/202312h03Edgar (US Regulatory)Current Report Filing (8-k)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
15/05/202322h25Edgar (US Regulatory)Quarterly Report (10-q)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
11/04/202322h32Edgar (US Regulatory)Annual Report (10-k)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
14/11/202222h09Edgar (US Regulatory)Quarterly Report (10-q)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
12/08/202222h16Edgar (US Regulatory)Quarterly Report (10-q)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
19/05/202223h10Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
19/05/202223h10Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
19/05/202223h09Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
19/05/202223h05Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
19/05/202223h05Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
16/05/202223h11Edgar (US Regulatory)Quarterly Report (10-q)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
15/11/202122h35Edgar (US Regulatory)Quarterly Report (10-q)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
15/11/202120h56Edgar (US Regulatory)Current Report Filing (8-k)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
18/10/202112h05Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
08/10/202121h52Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
17/08/202116h32Edgar (US Regulatory)Securities Registration Statement (s-1)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
06/08/202122h09Edgar (US Regulatory)Quarterly Report (10-q)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
04/08/202122h12Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
04/08/202122h11Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
04/08/202122h07Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
04/08/202122h04Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
22/07/202123h01Edgar (US Regulatory)Current Report Filing (8-k)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
19/07/202122h16Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
 Showing the most relevant articles for your search:USOTC:RGRX

Kürzlich von Ihnen besucht

USOTC
DURYY
Durr (PK)
EU
BOCAH
Bank of China 4750% unti...
NASDAQ
FSZYX
Fidelity Advisor Sustain...
USOTC
WILLF
Demant AS (PK)
BIT
UB03TW
UniCredit Bank
BIT
O8JQS5
Morgan Stanley BV
COIN
CONMUST
COIN
ZINUOETH
Zombie Inu [OLD]
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten